Epidemiological studies have enhanced the importance of high-density lipoprotein (HDL) as a risk factor for CAD, as well as disability and frailty in the oldest elderly. Therefore, HDL and molecules involved in HDL metabolism seem to be attractive candidates for longevity-promoting factors. A series of observational studies has demonstrated that the predominance of the larger, more lipid-rich HDL2 subclass is a reproducible phenotype among centenarians. This finding was recently evolved by nuclear magnetic resonance technology in quantification of lipoprotein particle size. However, results of investigations into the mechanisms underlying the lipoprotein profiles in the oldest elderly have been conflicting. Genetic variation in cholesteryl ester transfer protein (CETP), which is a carrier protein in reverse cholesterol transport, was demonstrated to have no association with longevity in one study, but to have positive impacts on large HDL particles and longevity in another. Regarding environmental factors, acute phase reactant and nutritional status are frequently associated with HDL-C levels in the oldest elderly, however, the causality of the association remains to be elucidated. Determination of the association between cognitive function and HDL in the oldest elderly is also a future task. To obtain further insight into the mechanistic roles of low HDL in the pathophysiology of geriatric syndrome, a much greater effort should be invested in this research field. J Atheroscler Thromb, 2004; 11: 246-252.
Introduction
Numerous epidemiological studies have confirmed that a low level of high-density lipoprotein cholesterol (HDL-C) is a strong risk factor for coronary artery disease (CAD) (1) . Moreover, clinical trials have also established that increasing HDL-C levels by drugs could recuce CAD risk (2, 3) . Recently, the importance of HDL as a risk factor for CAD or all-cause mortality has been emphasized, especially in the oldest population. Low HDL-C level, but not high LDL-C level, has been demonstrated to be associated with increased risk of CAD and stroke in the elderly over 85 years old (4) . Low HDL-C combined with low levels of serum albumin indicate higher mortality among elderly population (5) . Based on this evidence, one can hypothesize that intervention by elevating HDL levels or mechanism(s) for maintaining high HDL levels could reduce CAD risk, thus bringing about longer life expectancy. This hypothesis is compatible with observations that familial hyperalphalipoproteinemia often coexists with longevity (6) , and that higher HDL levels are found among healthy elderly aged 85-89 years as compared to those in middle-aged subjects (7) . Accordingly, HDL and molecules involved in HDL metabolism seem to be attractive candidates for longevity-promoting factors, and informative findings in this research field are accumulating. This article reviews the current status of our knowledge of HDL metabolism and its regulatory mechanism(s) in the oldest elderly, including centenarians.
HDL Cholesterol and Its Subpopulations in Centenarians
In the general population, HDL-C levels as well as total cholesterol decrease in older ages (8) . Menopause, change in body mass index, and age itself may be important determinants of decline in HDL levels among the elderly. However, results from centenarian studies have been conflicting. Some investigators have reported that centenarians showed a lipid profile similar to that of the middle-aged population (9) , but others have demonstrated lower total and HDL cholesterol in centenarians (10, 11) . This discrepancy may be attributable to differences in sampling, and the nutritional and functional status of centenarians (this issue is also described in later paragraphs). HDL particles are heterogeneous in apolipoprotein composition, density, particle size, and electrophoretic mobility. To fractionate HDL into subpopulations, various procedures including ultracentrifugation, polyanion precipitation, and gradient gel electrophoresis have been applied. HDL comprises two subclasses: the larger, more lipid-rich HDL2, and the smaller, denser HDL3. Lipoprotein profiles and HDL subclasses among elderly people have been extensively studied. Ettinger et al. measured HDL subfractions by a precipitation method in 1,127 female and 825 male subjects over 65 year old, and demonstrated that HDL2-C, but not HDL3-C, slightly increased with age in both men and women (12) . Although the analytic procedure was different, predominance of the HDL2 subfraction was observed among octogenarians (13) and centenarians. Barbagallo et al. examined HDL subfractions using polyacrylamide gradient gels in 16 female centenarians and 32 healthy normolipidemic postmenopausal women. They did not find any significant difference in lipid or apolipoprotein levels, however, the HDL2b level was increased, and the HDL3a level decreased in centenarians, compared to those in the controls (9) . We have also demonstrated relatively higher levels of HDL2-C among 42 centenarians by ultracentrifugation (11) . Recently, nuclear magnetic resonance (NMR) spectroscopy was efficiently applied for the quantification of lipoprotein particle size (14, 15) . Using these new methods, Barzilai et al. analyzed lipoprotein subclasses among Ashkenazi Jews over 95 years old and their offspring (16) . Although the differences in cholesterol levels were modest, they found that the particle sizes of both HDL and LDL were remarkably higher in the long-lived subjects compared with those in elderly controls from the Ashkenazi population. In addition, the offspring of long-lived subjects had intermediate HDL and LDL particle sizes between those of their parents and those of the controls, indicating that these lipoprotein phenotypes are heritable, and may be a causal biological candidate for longevity-promoting factors. Although these findings were obtained from cross-sectional studies and should be confirmed by longitudinal observation, the predominance of larger particles in HDL subclasses is the most reproducible phenotype among subjects who have reached extreme old age.
Factors Which Regulate HDL Metabolism in Centenarians Gene regulation of HDL cholesterol
The levels of plasma HDL-C and its subpopulations are regulated by a number of environmental, physiological, and genetic factors. Family and twin studies have estimated that the heritability of HDL-C levels varies from 35 to 66% (17, 18) . One report has suggested that the genetic influence of lipoproteins is not dependent on age (18) , however, another demonstrated that the genetic components in lipoprotein variations increased after menopause (19) . It will never be practicable to estimate the gene effects on lipoprotein levels in centenarians by a similar method, however, several genetic variations affecting HDL metabolism have been nominated as human longevity genes (Table 1) .
Cholesteryl ester transfer protein gene
The anti-atherogenic property of HDL particles is largely explained via its role in reverse cholesterol transport (RCT). Cholesteryl ester transfer protein (CETP) is a carrier protein in RCT, that mediates the transfer of cholesteryl esters from HDL to apoB-containing lipoproteins, thus enhancing RCT. Despite much accumulation of clinical and experimental data, the role of CETP in atherosclerosis remains to be elucidated. Several mutations at the CETP gene locus, which cause depletion of CETP activity and consequently high HDL-C in plasma, have been described, especially in Japanese subjects (20) (21) (22) . CETP deficiency has been demonstrated to regulate lipoprotein profiles in an antiatherogenic manner, inducing high levels of HDL subclass 2, and accordingly to be associated with longevity (20) . However, these mutations exhibited proatherogeneity when combined with a serum HDL-C level < 60 mg/dl (23), or with low activity of hepatic lipase (24) . Furthermore, in Omagari city, in which CETP deficiency caused by a G-to-A mutation at intron 14 is extremely frequent, the prevalence of the mutation was higher in patients with CAD, and lower in elderly subjects over 80 years old, as compared to that in control subjects, suggesting a negative impact of the mutation on longevity (25). The roles of CETP gene variations in longevity are also in debate. Recently, we investigated 256 centenarians and 190 controls (mean age, 40 years old; range, 22-65) for the implication of CETP deficiency and Taq1B polymorphisms of the CETP gene as a longevity factor (26) . In this study, we explored the finding that, although heterozygous CETP deficiency as well as the B2 allele of Taq1B polymorphisms were consistently associated with lower CETP mass and higher HDL-C concentrations, neither of these allelic variations were significantly associated with longevity. In contrast, at least one variant in the CETP gene was recently shown to have a strikingly higher impact on longevity. Barzilai et al. demonstrated in the above-mentioned study (16) that longlived Ashkenazi individuals and their offspring had a dramatically higher frequency of homozygosity for the 405 valine allele of CETP (VV genotype) as compared to that in ethnicity-matched controls. They also found that the VV genotype was associated with lower CETP concentration and increased HDL and LDL particle size, suggesting that this variant could be a genetic component for this unique lipoprotein phenotype among long-lived subjects, and therefore a promising candidate for a longevity gene. Although these findings await testing in other populations, Barzilai's study has raised the encouraging possibility that longitudinal observations of the offspring of long-lived subjects will determine whether large lipoprotein particles and the I405V polymorphism of the CETP gene are causal candidates for longevity.
Hepatic and lipoprotein lipase
In addition to CETP, hepatic lipase (HL), lipoprotein lipase (LPL), and ATP-binding cassette transporter 1 (ABCA1) are important components of RCT. Because these lipases and ABCA1 may regulate lipoprotein metabolism in concert with CETP, we simultaneously investigated associations of genetic variations involved in RCT and longevity (Table 1) .
LPL is a key enzyme that regulates the lipolysis of triglyceride-rich lipoproteins (TRL). Several polymorphisms of the LPL gene have been shown to be associated with atherogenic lipid profiles (27) (28) (29) , CAD (28, 29) , and diabetes (28), yet the results have been conflicting. In a study of 256 centenarians (26), we demonstrated a significant association between Pvu II (-/-) variants of the LPL gene and higher HDL-C concentration in centenarians, however, we found no association between this genetic polymorphism and longevity. Neither ABCA1 219R/K genotype nor the HL -514C/T promoter polymorphism had significant associations with longevity or lipid profiles in the centenarians or the controls. The negative results from our study do not necessarily contradict the putative roles of RCT in longevity. Exposure to Japanese traditional food with very low fat (10% of total calories) during the most susceptible period for CAD may exempt the obligation of RCT in longevity. Further study with a sample size large enough to calculate gene-gene interactions and to evaluate the overall efficacy of RCT is required to investigate what combination of candidate gene polymorphisms could be optimum for human longevity.
Effects of nutritional status and inflammation
Other than genetic components, numerous environmental factors, including weight change, diet and nutrition, use of medications, smoking habit, acute phase response, undiagnosed disease, physical activities, and aging itself, may substantially affect HDL-C levels. Recently, as evidence suggesting clinical implications of Creactive protein (CRP) in predicting cardiovascular risk has been increasing, associations between acute phase reactants such as CRP and interleukin 6 (IL-6), and HDL have been frequently investigated. In an acute phase model of rabbits, remodeling of HDL composition includ- (32) . In epidemiological studies, an inverse correlation of CRP with HDL-C levels was observed among general populations of elderly (33) and hospitalized elderly patients (34) . Regarding the oldest elderly, however, we should consider the effects of age-related immune alteration or activation, which is ubiquitously observed in this exceptional population (35) . A modest increase in CRP (11, 26) , IL-6 (11), and tumor nocrosis factor-α (TNF-α) (36) was demonstrated in centenarians even when they were in good health. Moreover, low-grade inflammatory activation is often associated with undernutrition indicated by hypoalbuminemia, poor health status, and chronic conditions such as atherosclerosis and dementia in the oldest elderly. Therefore, we conducted a comprehensive analysis of diet and nutritional status, inflammatory markers, and physical and cognitive function as well as apo E polymorphisms, as predictors for lipid profiles in centenarians (Table 2 ). In the study, the levels of albumin, prealbumin, and transferrin showed a strong and positive correlation with HDL-C and apo A1. Log-transformed CRP and IL-6 were inversely correlated with HDL and apo A1. Multiple regression analysis was performed to evaluate independent contributions of these factors to the variance of lipid profiles, and indicated that the level of albumin was the strongest predictor of HDL-C in centenarians (11) . However, in the oldest elderly, malnutrition often coexists with inflammatory activation, and the albumin level does not necessary reflect nutritional status. So, it seems to be difficult to distinguish the independent effects of nutritional status and inflammation markers on lipoprotein profiles, even by longitudinal observation.
Cognitive function and HDL
Several lines of evidence have suggested that low HDL-C is associated with cognitive decline in the oldest elderly. Although the pathophysiology of dementia in this population has not been fully uncovered, vascular components have been generally implied. This may explain in part the association between HDL and dementia in those of extremely old age, however, van Exel et al. (37) demonstrated that cognitive impairment in the oldest elderly was at least partially independent of atherosclerotic disease. They examined 561 subjects at least 85 years old for associations between serum lipids, cognitive impairment, and CAD, and demonstrated that a low MMSE score was associated with a low HDL-C level, even when subjects with CAD and stroke were excluded. They proposed that the antiaggregation and anti-inflammatory properties of HDL might explain the associations between HDL and cognitive impairment. In centenarians, we demonstrated that the level of HDL-C, but not TC or LDL-C, was significantly lower in the subset with cognitive impairment (11) . In addition to cross-sectional design, the accumulation of lower albumin, higher CRP and IL-6, lower ADL scores, and the higher rate of apo E4 in this subset made it difficult to determine the causality of as- sociation between dementia and low HDL. Recently, statin treatment for more than 5,000 elderly over 70 years old lowered LDL-C by 34%, elevated HDL by 5% and reduced cardiovascular death, but had no impact on cognitive function and disability (38) . Based on these findings, cognitive impairment in the oldest elderly is multifactorial, and low HDL-C may be a reproducible marker, rather than a determinant.
Conclusion
There is no doubt that low HDL-C is a potent risk factor for CAD in the elderly. Furthermore, low HDL-C can be a reliable marker for frailty and poor prognosis among the oldest elderly, when combined with hypoalubuminemia and/or proinflammatory cytokinemia. A series of epidemiological studies has described a significant association of large particle size in HDL, and presumably in LDL, with human longevity. Very recently, Geesaman et al. first identified a genetic variant of microsomal transfer protein (MTP) as a human longevity gene by a genome-wide linkage study using 137 sibships of long-lived subjects, followed by haplotype-based mapping (39, 40) . These findings suggest a strong implication of lipoprotein metabolism in the process of living an extremely long life. Compared with the fundamental evidence from the clinical research field of cardiology, longitudinal and interventional studies from the view point of gerontology have been lacking. It is of special interest whether elevation of HDL-C by pharmacological intervention could improve cogniftive function in the oldest elderly. To obtain further insight into the mechanistic roles of low HDL in the pathophysiology of geriatric syndrome, a much greater effort should be invested in this research field.
